- Home
- MTSI vs INM Comparison
MTSI vs INM Comparison
Compare MTSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTSI
- INM
- Stock Information
- Founded
- MTSI 1950
- INM 1981
- Country
- MTSI United States
- INM Canada
- Employees
- MTSI N/A
- INM N/A
- Industry
- MTSI Semiconductors
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MTSI Technology
- INM Health Care
- Exchange
- MTSI Nasdaq
- INM Nasdaq
- Market Cap
- MTSI 9.2B
- INM 5.0M
- IPO Year
- MTSI 2012
- INM N/A
- Fundamental
- Price
- MTSI $137.05
- INM $2.10
- Analyst Decision
- MTSI Strong Buy
- INM
- Analyst Count
- MTSI 7
- INM 0
- Target Price
- MTSI $147.71
- INM N/A
- AVG Volume (30 Days)
- MTSI 1.0M
- INM 120.8K
- Earning Date
- MTSI 11-06-2025
- INM 11-13-2025
- Dividend Yield
- MTSI N/A
- INM N/A
- EPS Growth
- MTSI N/A
- INM N/A
- EPS
- MTSI N/A
- INM N/A
- Revenue
- MTSI $906,798,000.00
- INM $4,942,633.00
- Revenue This Year
- MTSI $35.10
- INM N/A
- Revenue Next Year
- MTSI $13.73
- INM N/A
- P/E Ratio
- MTSI N/A
- INM N/A
- Revenue Growth
- MTSI 33.50
- INM 7.50
- 52 Week Low
- MTSI $84.00
- INM $1.72
- 52 Week High
- MTSI $152.50
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- MTSI 58.74
- INM 43.02
- Support Level
- MTSI $123.86
- INM $2.04
- Resistance Level
- MTSI $140.98
- INM $2.26
- Average True Range (ATR)
- MTSI 4.86
- INM 0.14
- MACD
- MTSI 1.09
- INM -0.01
- Stochastic Oscillator
- MTSI 78.97
- INM 13.05
About MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.